Tahseen Mozaffar, MD, FAAN


The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAAN

On Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]

Bridget A. Bagert, MD, MPH


The Relationship Between Epstein-Barr Virus and Multiple Sclerosis

The paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.

Amy Brin, MSN, MA, PCNS-BC


Adding Experience to the National Health Institute Council: Amy Brin, MSN, MA, PCNS-BC

The chief executive officer of the Child Neurology Foundation provided insight on her new position at the National Health Institute’s National Advisory Neurological Disorders and Stroke Council. [WATCH TIME: 4 minutes]

Gabrielle Rushing, PhD


Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhD

The director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]

Eric McDade, DO


Future Outlook for Alzheimer’s Disease

Drs Atri, Cohen, Sabbagh and McDade share their enthusiasm and optimism about the future outlook for Alzheimer’s disease.

David R. Zook, JD


Connecting ALS: How New Drug Coverage Decisions Are Made

In this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.

Ana Pereira, MD


Ana Pereira, MD: Repurposing Riluzole for Alzheimer Disease

The assistant professor of neurology and neuroscience at Mount Sinai Medical Center detailed the promise marked by the results of a recent pilot trial of riluzole in Alzheimer disease.

Jeffrey Wilken, PhD


Future of Cognition in Multiple Sclerosis

Ahmed Obeidat, MD, PhD; Randall Schapiro, MD, FAAN; and Jeffrey Wilken, PhD, share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.

Manolo Bellotto, PhD


A New Approach to Protein Misfolding in Parkinson Disease

Previously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.

Eric Zhou, PhD


Improvements to the Detection, Psychosocial Aspects of Narcolepsy in Adolescents: Eric Zhou, PhD

The assistant professor of pediatrics at Harvard Medical School provided perspective on the care needs of adolescents and young adults with narcolepsy, and the importance of early detection of lingering issues. [WATCH TIME: 3 minutes]

Rohini K. Coorg, MD


Less Invasive Epilepsy Surgery May Help Turn Candidates Into Consults

Recent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.

Sait Ashina, MD


Future Directions for the Management of Migraine

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.

Erika Fullwood Augustine, MD, MS


Evolving Landscape of Pediatric Neurology: Erika Fullwood Augustine, MD, MS

The associate chief science officer at Kennedy Krieger Institute shared thoughts on the state of pediatric neurology and the significance of being named winner of the Sydney Carter Award. [WATCH TIME: 3 minutes]

Deborah Miller, PhD


Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhD

The staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]

Farrah Mateen, MD, PhD


Creating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhD

The associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital discussed the ways employers and clinicians can alleviate work hardships experienced by patients with NMOSD. [WATCH TIME: 3 minutes]

David Fischer, MD


Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD

The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]

Douglas Scharre, MD


Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD

Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]

Mitzi Joi Williams, MD


Pros and Cons of Telemedicine for Multiple Sclerosis: Mitzi Joi Williams, MD

The founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her reasoning as to why she hopes telemedicine is here to stay. [WATCH TIME: 4 minutes]

Debra Davis, CRNP


Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.

Indu Subramanian, MD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Michael Levy, MD, PhD


Subgroup Analyses of Ravulizumab Demonstrates Effectiveness Across Patient Populations: Michael Levy, MD, PhD

The associate professor of neurology at Harvard Medical School talked about the subgroup analysis on ravulizumab in NMOSD that was presented at the 2023 AAN Annual Meeting. [WATCH TIME: 5 minutes]

Deepti Zutshi, MD, FAAN


Expensive Antiseizure Medications Cause for Concern for Patients with Epilepsy: Deepti Zutshi, MD, FAAN

The associate professor of neurology at Wayne State University in Detroit, Michigan, spoke about expensive antiseizure medications for epilepsy along with spending for Medicare and Medicaid at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]

Marcia Morita-Sherman, MD, PhD


Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?

Thomas Topley, MBA


The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley

The executive director of the Bensalem Rescue Squad spoke specifically to how the MSU has shifted the paradigm of care that EMS can provide to individuals in the community. [WATCH TIME: 4 minutes]

Glenn Graham, MD, PhD


AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]

Michael Weiner, MD


Advancements in the Alzheimer Disease Field: Michael Weiner, MD

The director of the Brain Health Registry discussed advancements in AD, following the publication of a systematic review on the predictors of Aß.

Lawrence Elmer, MD, PhD


Remaining Questions and Next Steps for Parkinson Agent P2B001: Lawrence Elmer, MD, PhD; Cheryl Fitzer-Attas, PhD

The medical director of the Center for Neurological Disorders at the University of Toledo discussed positive phase 3 findings assessing P2B001, and how the agent would potentially fit in the Parkinson treatment landscape. [WATCH TIME: 4 minutes]

Rachelle S. Doody, MD, PhD


Roche’s NeuroToolKit in Alzheimer Disease Research: Rachelle S. Doody, MD, PhD

The global head of Neurodegeneration at Roche/Genentech shared insight into the development of the company’s NeuroToolKit and its use in its Alzheimer disease research.

Bryan Walker, MHS, PA-C


Managing MS in the Community: Advice and Resources

Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).

Russell Cerejo, MD


Rehab Process and Need for Improved Guidelines of Basilar Artery Occlusions: Russell Cerejo, MD

The vascular neurologist at Allegheny Health Network provided insight on the need to create consensus guidelines that further explain the treatment, management, and rehab of basilar artery occlusions. [WATCH TIME: 3 minutes]

© 2023 MJH Life Sciences

All rights reserved.